ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 83 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $491,000 | -7.0% | 100,000 | 0.0% | 0.97% | -7.9% |
| Q2 2021 | $528,000 | +10.0% | 100,000 | 0.0% | 1.05% | -1.6% |
| Q1 2021 | $480,000 | +10.9% | 100,000 | 0.0% | 1.07% | -26.7% |
| Q4 2020 | $433,000 | +5.1% | 100,000 | 0.0% | 1.46% | +7.4% |
| Q3 2020 | $412,000 | -28.7% | 100,000 | -50.0% | 1.36% | +39.7% |
| Q1 2020 | $578,000 | -23.7% | 200,000 | 0.0% | 0.97% | -56.4% |
| Q4 2019 | $758,000 | -25.9% | 200,000 | 0.0% | 2.23% | +20.7% |
| Q3 2019 | $1,023,000 | -17.5% | 200,000 | 0.0% | 1.85% | -20.6% |
| Q2 2019 | $1,240,000 | +74.4% | 200,000 | +100.0% | 2.33% | -15.1% |
| Q1 2019 | $711,000 | – | 100,000 | – | 2.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |